Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.5531 | 0.7255 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0021 | 0.5386 | 0.5386 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.5531 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.5531 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0021 | 0.5386 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.5531 | 0.5531 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0028 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.5531 | 0.5531 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.7623 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 1 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0021 | 0.5386 | 0.5386 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0021 | 0.541 | 0.165 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.5531 | 0.5531 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0024 | 0.7623 | 0.7623 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0028 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0021 | 0.5386 | 0.4987 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.5531 | 0.5144 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0021 | 0.5386 | 0.7065 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0013 | 0.0796 | 0.0796 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.5531 | 0.5531 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0.0796 | 0.0796 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0.5531 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0021 | 0.5386 | 0.5386 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0796 | 0.1044 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0021 | 0.5386 | 0.5386 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.5531 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0021 | 0.5386 | 0.7065 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.5531 | 0.5 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0021 | 0.5386 | 0.4987 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0021 | 0.5386 | 0.5386 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.5531 | 0.5531 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0028 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0021 | 0.541 | 0.541 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.5531 | 0.5144 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.5531 | 0.5 |
Toxoplasma gondii | FATC domain-containing protein | 0.0028 | 1 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.5531 | 0.5531 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0021 | 0.5386 | 0.5386 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.5531 | 0.5 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.5531 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.5531 | 0.5531 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.5531 | 0.5531 |
Echinococcus granulosus | serine protein kinase ATM | 0.0028 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0021 | 0.5386 | 0.4987 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0028 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0021 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0021 | 0.5386 | 0.5386 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.5531 | 0.5531 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0021 | 0.5386 | 0.4987 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0021 | 0.5386 | 0.4987 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.5531 | 0.5531 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0021 | 0.5386 | 0.5386 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.